Bdr Lifesciences Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is NINTEDANIB ESYLATE, with a corresponding US DMF Number 40208.
Remarkably, this DMF maintains an Active status since its submission on September 20, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 29, 2024, and payment made on August 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II